Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RNA
#1652
Avidity Biosciences, Inc. Common Stock
14.750
0
-79.74%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-79.74%
Monthly Change
-79.67%
6 month change
-79.03%
Year Change
-79.03%
Previous Close
72.800
0
Open
14.750
0
Bid
Ask
Low
14.750
0
High
14.750
0
Volume
25
Markets
US Stock Market
Healthcare
RNA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.58 M
47.75 M
70.81 M
79.72 M
120.21 M
155.15 M
—
Valuation ratios
Enterprise value
637.7 M
814.68 M
1.09 B
545.15 M
3.28 B
10.81 B
23.74 B
Price to earnings ratio
-0.07
-0.01
-6.06
-3.15
-10.06
-14.51
-42.81
Price to sales ratio
-0.46
-0.09
114.51
69.96
297.77
529.62
1 512.55
Price to cash flow ratio
-0.08
-0.01
7.75
5.62
10.78
15.27
41.94
Price to book ratio
-0.01
-0
1.83
1.34
2.28
5.88
8.1
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.13
-0.28
-0.27
-0.34
-0.21
-0.35
-0.4
Return on equity %
-0.14
-0.31
-0.3
-0.42
-0.23
-0.41
-0.45
Return on invested capital %
-1 954.4
-2 299.28
-2 129.73
-1 908.04
-2 666.54
-372.86
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-652.38
-1 265.83
-1 939.65
-2 464.41
-3 477.43
-3 977.3
-43.91 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-653.53
-1 265.38
-1 886.33
-2 219.87
-2 957.71
-3 650.39
-40.42 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
22.74
13.86
12
7.58
15.73
9.2
46.94
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.02
0.02
0.02
0.01
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
—
—
—
—
—
—
Long term debt to total equity ratio
0.01
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
301.07
2 821.82
-2.61
-1.63
-2.7
-4.72
-4.92
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
-2 661.31
-12.07 K
11.71
8.15
13.44
2.78
25.53
Net current asset value per share
-2 690.34
-12.24 K
11.94
8.37
13.82
13.06
48.69
Tangible book value per share
-2 483.86
-11.35 K
11.08
6.86
12.77
12.26
46.02
Working capital per share
-2 572.02
-11.35 K
10.95
7.27
12.94
11.64
44.28
Book value per share
-2 483.86
-11.35 K
11.08
6.86
12.77
12.26
46.02
News
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories! - TipRanks.com
Avidity Bio earnings missed by $0.30, revenue fell short of estimates
Avidity postpones stockholder meeting, sets merger dates
Avidity’s myotonic dystrophy drug shows promising results in trial
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
Vaccine Makers Curtail Research and Cut Jobs
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
F.D.A. Refuses to Review Moderna Flu Vaccine
Novartis Beats on Q4 Earnings, Entresto Generics Pressure Sales
Avidity Biosciences stock hits all-time high at 72.74 USD
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Sonoma Pharmaceuticals appoints new board member and senior executive